KAI-1678 is an inhibitor of epsilon protein kinase C in the treatment of neuropathic pain in patients with PHN.
CAT No: 10-101-144
KAI-1678 is a synthetic small molecule known for its potent and selective antagonistic activity against the epsilon isoform of protein kinase C (PKCε). As a non-peptide inhibitor, KAI-1678 has garnered significant attention in biochemical and pharmacological research due to its capacity to modulate PKCε-mediated signaling pathways. PKCε plays a crucial role in various cellular processes, including signal transduction, neuronal sensitization, and inflammatory responses. The compound's specificity and mechanism of action make it a valuable tool for dissecting the functional roles of PKCε in diverse experimental systems, supporting both fundamental research and advanced studies in cellular signaling.
Cell signaling research: KAI-1678 is extensively utilized in the investigation of PKCε-dependent signaling cascades. By selectively inhibiting PKCε activity, researchers can delineate the specific contributions of this isoform to broader protein kinase C family functions. Such studies are instrumental in mapping the downstream effects of PKCε activation in cellular models, enabling a more precise understanding of signal transduction networks. The compound's high selectivity allows for targeted interrogation of PKCε without significant off-target effects on other PKC isoforms, thus providing clarity in complex signaling environments.
Neuroscience studies: The role of PKCε in neuronal sensitization and synaptic plasticity has made KAI-1678 a valuable agent in neurobiological research. By modulating PKCε activity, scientists can explore its involvement in processes such as neurotransmitter release, receptor regulation, and neuronal excitability. The compound is particularly useful in experimental models designed to assess the molecular mechanisms underlying pain perception, neural adaptation, and the modulation of nociceptive pathways. These studies contribute to a deeper understanding of neuronal function and the intricate regulation of neural circuits.
Inflammatory pathway analysis: In the context of inflammation research, KAI-1678 serves as a critical tool for probing the signaling events that drive pro-inflammatory mediator production. PKCε is implicated in the regulation of cytokine release and the activation of inflammatory cells. By inhibiting this kinase, researchers can dissect the molecular steps involved in inflammatory signaling and identify potential nodes of regulation within these pathways. This application is especially relevant in studies aiming to characterize the biochemical underpinnings of inflammatory diseases and immune cell activation.
Target validation and drug discovery: The specificity of KAI-1678 for PKCε makes it an excellent probe for target validation in preclinical research. Scientists employ the compound to confirm the functional relevance of PKCε in various cellular and animal models, which is a critical step in the early phases of drug discovery. Through the selective inhibition of PKCε, it is possible to evaluate the consequences of target modulation, assess on-target effects, and guide the design of future therapeutic candidates. This targeted approach enhances the efficiency and reliability of translational research pipelines.
Biochemical assay development: KAI-1678 is also used in the optimization and validation of in vitro biochemical assays aimed at quantifying PKCε activity. Its well-characterized inhibitory properties make it suitable as a positive control or reference standard in kinase assays, facilitating the assessment of assay sensitivity, specificity, and reproducibility. By incorporating this compound into assay development workflows, laboratories can ensure robust detection of PKCε activity and streamline the evaluation of novel modulators or inhibitors in high-throughput screening formats.
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More